Lupin launches generic Nystatin and Triamcinolone Acetonide Cream
30 November 2018 | News
It is indicated for the treatment of cutaneous candidiasis
Pharma company Lupin has announced the launch of Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 %, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin's Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 % is the generic equivalent of Taro Pharmaceuticals' Nystatin and Triamcinolone Acetonide Cream.
It is indicated for the treatment of cutaneous candidiasis.
Nystatin and Triamcinolone Acetonide Cream had annual sales of $54.3 million in the US (IQVIA MAT September 2018).
